Millán Núñez-Cortés Jesús, Montoya Juan Pedro-Botet, Salas Xavier Pintó, Hernández Mijares Antonio, Carey Vincent J, Hermans Michel P, Sacks Frank M, Fruchart Jean-Charles
Hospital General Universitario Gregorio Marañón, Universidad Complutense, Madrid, España.
Endocrinol Nutr. 2011 Jan;58(1):38-47. doi: 10.1016/j.endonu.2010.10.004. Epub 2011 Jan 3.
The R3i Foundation (Residual Risk Reduction Initiative), an independent, multinational and academic organization, is conducting the REALIST (Residual Risk, Lipids and Standard Therapies) study in 40 centers in different countries. This is a retrospective epidemiological study, designed to provide new data on the residual risk of major coronary events attributable to lipid abnormalities in patients receiving the current standard treatment. The initial results are expected in mid 2010, and the overall results at the end of 2010.
R3i基金会（残余风险降低倡议组织）是一个独立的跨国学术组织，正在不同国家的40个中心开展“现实主义（残余风险、血脂与标准治疗）”研究。这是一项回顾性流行病学研究，旨在提供有关接受当前标准治疗的患者中，脂质异常所致主要冠状动脉事件残余风险的新数据。初步结果预计在2010年年中得出，整体结果将于2010年底得出。
